Guido Mannaioni

Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy

C. Ghelardini, A. Masi, M. Romanelli, 2018, Neuropharmacology.

Harnessing ionic mechanisms to achieve disease modification in neurodegenerative disorders.

A. Masi, R. Narducci, R. Narducci, 2019, Pharmacological research.

PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca2+-permeable AMPA receptors

A. Masi, F. Moroni, G. Mannaioni, 2014, Neurobiology of Disease.

Sulfate esters of hydroxy amino acids as stereospecific glutamate receptor agonists.

F. Moroni, B. Natalini, R. Pellicciari, 1994, European journal of pharmacology.

Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABAB receptor-mediated mechanism

E. Domi, Ana Domi, M. Petrella, 2024, Neuropharmacology.

MPP+‐dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons

A. Masi, R. Narducci, F. Moroni, 2013, British journal of pharmacology.